HomeAbout Investor AwarenessClient ServicesClient Success StoriesManagement TeamClient ProfilesContact Us

Client Profiles

 

Cleveland BioLabsCleveland BioLabs
NASDAQ: CBLI
www.clevelandbiolabs.com
Cleveland BioLabs, Inc. is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant medical need. CBLI’s programs are focused on the use of novel toll-like receptor agonists to activate the immune system for therapeutic benefit. The Company's most advanced product candidate is entolimod, which is being developed as a radiation countermeasure and an immunotherapy for oncology and other indications. The company maintains strategic relationships with the Cleveland Clinic and Roswell Park Cancer Institute.

CBLI is focused on achieving two major objectives:

  1. Commercializing entolimod as a medical radiation countermeasure through pre-Emergency Use Authorization.
  2. Achieving clinical validation and partnerships for cancer immunotherapies and vaccine adjuvant technology.
Yahoo Data and NewsCompany Web Site

ICON LEGEND
Yahoo Data and News
 Yahoo Finance Data & News
Company Profile Company Profile (PDF)
Company Web Site Company Web Site

News and Updates

Cleveland BioLabs Announces New Patents Strengthening Entolimod Portfolio

Buffalo, NY – August 18, 2015 – Cleveland BioLabs, Inc. (NASDAQ:CBLI) today announced the allowance or issuance of several new patents for entolimod in the U.S. and other countries, further bolstering its patent position.

(full story)

Sparta Commercial Welcomes National Powersports Distributors to Its Cyclechex Program

New York, NY, Aug. 19, 2015 -- Sparta Commercial Services, Inc. (SRCO) today announced that National Powersports Distributors in New Hampshire has begun to purchase Cyclechex Motorcycle Title History Reports to provide to their customers, at no charge.

 

(full story)

Cleveland BioLabs Appoints Langdon Miller, MD, as President

BUFFALO, NY-- May 5, 2015 - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the appointment of Langdon L. Miller, M.D., as President and Chief Medical Officer, effective immediately.

(full story)

More Articles
 

Upcoming Events

There are no events to display at this time.
Complete Events List
 

CorbusCorbus Pharmaceuticals, Inc.
NASDAQ: CRBP
www.corbuspharma.com
Corbus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat life threatening ("orphan") inflammatory-fibrotic diseases with clear unmet needs. The Company’s lead product Resunab is a first- in-class oral anti-inflammatory expected to commence Phase-2a clinical trials for the treatment of cystic fibrosis and scleroderma pending FDA approval of IND.

About Resunab™
Resunab is a novel synthetic oral drug with unique anti-inflammatory and anti-fibrotic activity. Pre-clinical and Phase 1 studies have shown Resunab to have an excellent safety profile in humans and promising potency. Resunab binds to the CB2 receptor of immune cells and triggers a process known as "inflammatory resolution", in effect turning chronic inflammation "off."
Yahoo Data and NewsCompany Web Site

Sparta Commercial Services, Inc.Sparta Commercial Services, Inc.
OTC: SRCO
spartacommercial.com
Sparta Commercial Services, Inc. is a leader, in developing, managing, and servicing custom mobile apps for dealer networks and businesses, in providing motor vehicle history reporting to dealers and consumers, and offering and administering vehicle and capital lease programs for municipalities.

Sparta's Mobile Applications Division offers two customizable mobile app products specifically designed for vehicles dealers and for small and growing companies.

iMobileApp (imobileapp.com) is the newest mobile app product from Sparta - providing diverse small and growing companies with a customized mobile app for their businesses, at a fraction of the cost of traditional and web marketing.

Specialty Mobile Apps (specialtymobileapps.com) is a product that gives vehicle dealers their own branded mobile app. The app allows dealers to stay in contact with their customers and communicate upcoming and ongoing promotions, special events, new and used inventory, and more.

Specialty Reports, Inc., a subsidiary of Sparta Commercial Services, provides detailed used vehicle title history reports to dealers, insurance companies, credit unions, etc., as well as to consumers. Specialty Reports (specialtyreportsinc.com) is trusted by industry professionals to provide buyers accurate, timely, and thorough title history reports. The Company targets four motor vehicle markets through carvinreport.com (automobiles and light trucks), cyclechex.com (motorcycles), rvchecks.com (recreational vehicles) and truckchex.com (commercial trucks).

Sparta's Municipal Leasing Division (spartamunicipal.com) offers and administers a specialized municipal leasing program for local and state agencies. The Company is dedicated to serving jurisdictions with small and growing vehicle fleets who seek a better and more economical way to finance their essential equipment needs - from police motorcycles and cruisers, to EMS equipment and busses, to virtually any type of equipment a municipality requires. The Municipal Leasing Division also works with larger jurisdictions to provide competitive leasing facilities for specific segments of their fleet portfolio.
Yahoo Data and NewsCompany Web Site

 

lower_banner

lower_banner-02

  Disclaimer     Financial Glossary

©2013 Investor Awareness, Inc. All rights reserved